Novartis Drug Exjade(R) Recommended by CHMP for EU Approval to Treat …

Published November 25, 2012

Novartis drug Exjade(R) recommended by CHMP for EU approval to treat …

Filed under: drug treatment news 2011

Novartis International AG / Novartis drug Exjade® recommended by CHMP for EU approval to treat patients with non-transfusion-dependent thalassemia syndromes . Processed and transmitted by Thomson Reuters ONE. …. In 2011, the Group's continuing …
Read more on Reuters